Cargando…
Single-sample expression-based chemo-sensitivity score improves survival associations independently from genomic mutations for ovarian cancer Patients
Platinum-based chemotherapies are first-line treatments for ovarian cancer (OC) patients. Although chemotherapy has a high initial response rate, some patients exhibit inherent chemo-resistance. With advancements of molecular and genomic profiling, it is of high interest to identify molecular and ge...
Autores principales: | Zimmermann, Michael T., Jiang, Guoqian, Wang, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Informatics Association
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5001782/ https://www.ncbi.nlm.nih.gov/pubmed/27570657 |
Ejemplares similares
-
Non-classical estrogen signaling in ovarian cancer improves chemo-sensitivity and patients outcome
por: Hao, Dapeng, et al.
Publicado: (2019) -
Ovarian cancer risk score predicts chemo-response and outcome in epithelial ovarian carcinoma patients
por: Lu, Hsiao-Yun, et al.
Publicado: (2020) -
Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitization
por: Ray, Upasana, et al.
Publicado: (2021) -
SB225002 Promotes Mitotic Catastrophe in Chemo-Sensitive and -Resistant Ovarian Cancer Cells Independent of p53 Status In Vitro
por: Du, Meirong, et al.
Publicado: (2013) -
Nanotechnology-Based Cisplatin Intracellular Delivery to Enhance Chemo-Sensitivity of Ovarian Cancer
por: Bortot, Barbara, et al.
Publicado: (2020)